Ernoff GF: Shiverer: an autosomal recessive mutant mouse with myelin deficiency. J Hered 1981, 72:128. 64. Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB: -Amyloid efflux mediated by p-glycoprotein. J Neurochem 2001, 76:1121128. 65. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV: LRP/amyloid -peptide interaction mediates differential brain efflux of A isoforms. Neuron 2004, 43:33344. 66. Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S: A-degrading enzymes in Alzheimer’s disease. Brain Pathol 2008, 18:24052. 67. Nagara H, Suzuki K: Chronological study of oligodendroglial alterations and myelination in quaking mice. Neuropathol Appl Neurobiol 1981, 7:13549. 68. Best TT, Skoff RP, Bartlett WP: Astroglial plasticity in hemizygous and heterozygous jimpy mice. Int J Dev Neurosci 1988, 6:397. 69. Dyer CA, Kendler A, Jean-Guillaume D, Awatramani R, Lee A, Mason LM, Kamholz J: GFAP-positive and myelin marker-positive glia in normal and pathologic environments. J Neurosci Res 2000, 60:41226. 70. Maeda A, Sobel RA: Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 1996, 55:30009.Namodenoson 71. Liuzzi GM, Latronico T, Fasano A, Carlone G, Riccio P: Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment. Mult Scler 2004, 10:29097. 72. del Zoppo GJ, Milner R, Mabuchi T, Hung S, Wang X, Berg GI, Koziol JA: Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007, 38:64651. 73. del Zoppo GJ, Frankowski H, Gu YH, Osada T, Kanazawa M, Milner R, Wang X, Hosomi N, Mabuchi T, Koziol JA: Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation. J Cereb Blood Flow Metab 2012, 32:91932. 74. Roher AE, Kasunic TC, Woods AS, Cotter RJ, Ball MJ, Fridman R: Proteolysis of A peptide from Alzheimer disease brain by gelatinase A.Lumasiran Biochem Biophys Res Commun 1994, 205:1755761. 75. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA: Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid- peptide (10). J Neurosci 1996, 16:7910919. 76. Yan P, Hu X, Song H, Yin K, Bateman RJ, Cirrito JR, Xiao Q, Hsu FF, Turk JW, Xu J, Hsu CY, Holtzman DM, Lee JM: Matrix metalloproteinase-9 degrades amyloid- fibrils in vitro and compact plaques in situ.PMID:24578169 J Biol Chem 2006, 281:245664574. 77. Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, Bateman R, Song H, Hsu FF, Turk J, Xu J, Hsu CY, Mills JC, Holtzman DM, Lee JM: Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid- peptide catabolism. J Neurosci 2006, 26:109390948. 78. White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, Hoke DE, Holsinger RM, Evin G, Cherny RA, Hill AF, Barnham KJ, Li QX, Bush AI,Ou-Yang and Van Nostrand Journal of Neuroinflammation 2013, 10:134 http://www.jneuroinflammation/content/10/1/Page 12 ofMasters CL: Degradation of the Alzheimer disease amyloid -peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 2006, 281:176707680. 79. Kotarba AE, Aucoin DS, Hoos MD, Smith SO, Van Nostrand WE: Fine mapping of the amyloid ss-protein binding site on myelin basic protein. Biochemistry 2013, 52(15):256.